🇺🇸 FDA
Patent

US 6384221

Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-&agr;]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

expired A61KA61K31/519A61P

Quick answer

US patent 6384221 (Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-&agr;]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto) held by Neurocrine Biosciences, Inc. expires Mon May 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue May 07 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K31/519, A61P, A61P5/02